Navigation Links
Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
Date:3/9/2009

tion. The award was given for the paper, "Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept," which was published in Nutrition: The International Journal of Applied and Basic Nutritional Sciences.
  • Enhanced Company Leadership. Throughout 2008, Interleukin Genetics, Inc. enhanced its management team with the addition of a new chief financial officer, vice president of marketing, senior business development executive, and staffed other critical positions in research and development, public relations, human resources, laboratory management and computer and information technology.

    • The Company reported revenues of $10.0 million and a net loss of $6.7 million, or $(0.21) per basic and diluted common share, for the year ended December 31, 2008, compared to revenues in 2007 of $9.7 million and a net loss of $6.2 million, or $(0.22) per basic and diluted common share. The revenue increase is primarily attributable to growth in consumer product revenue in combination with increased royalty and contract research revenue offset by a slight decrease in genetic testing revenue.

    Research and development expenses were $3.6 million for the year ended December 31, 2008 compared to $2.9 million for the year ended December 31, 2007. The increase is attributable to expenses relating to the Company's sponsored research agreement with Yonsei University, as well as additional expenses relating to our patent portfolio.

    Selling, general and administrative expenses were $7.0 million for the year ended December 31, 2008 compared to $6.4 million for the prior year. The increase is primarily attributable to increased promotional and advertising expenses, as well as increased expenses due to additional headcount.

    Fourth Quarter Results

    Revenue for the three months ended D
    '/>"/>

    SOURCE Interleukin Genetics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Interleukin Genetics Announces Management and Board Appointments
    2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
    3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
    4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
    5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
    6. Interleukin Genetics Retains Top Life Science Communications Firms
    7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
    8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
    9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
    10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
    11. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/17/2010)... sheets a single atom thicknow appears to be ... to recent research* at the National Institute of ... Pennsylvania. The findings suggest stacks of graphene layers ... fuel cells and other applications. , Graphene has ... years due to its conductive, thermal and optical ...
    (Date:3/17/2010)... studies highlight need for innovation to meet growing global needs ... ... March 17, 2010 -- Studies released today at a symposium ... modern agriculture has provided to society and emphasized the importance ... food, feed, fiber and industrial needs., , ,Research presented by ...
    (Date:3/17/2010)... QUÉBEC CITY, March 17 /PRNewswire-FirstCall/ - Æterna Zentaris Inc. ( AEZS, TSX: ... announce its fourth quarter and full year 2009 financial and operating results before market ... call and webcast to discuss these results later that same day at 10:00 ... ... ...
    (Date:3/17/2010)... and pressure transmitters moves to Hatfield, Pa. , ... ... Brooks Instrument, a world-leading provider of advanced flow measurement, control ... recently acquired pressure gauge product family at its headquarters in ... products through its acquisition of certain assets of Celerity’s Instrumentation ...
    Breaking Biology Technology:Layered graphene sheets could solve hydrogen storage issues 2Global Food Security Depends on Modern Agriculture 2Global Food Security Depends on Modern Agriculture 3Global Food Security Depends on Modern Agriculture 4Æterna Zentaris to Announce Fourth Quarter Full Year 2009 Financial and Operating Results on March 24, 2010 2Brooks Instrument Opens Pressure Gauge Production Line 2Brooks Instrument Opens Pressure Gauge Production Line 3
    ... Technologies, Inc.,a provider of innovative droplet-based solutions for ... with the Scripps,Translational Science Institute (STSI) to utilize ... key bottleneck in large-scale,targeted sequencing studies., "RainDance ... effort to discover,inherited genetic variations that may play ...
    ... MONTREAL, Aug. 28 /PRNewswire/ - Enerkem Inc., ... today the appointment of,two new Vice-Presidents to ... & Implementation and Mrs. Marie-Helene Labrie,Vice-President, Government ... to add these seasoned executives to our ...
    ... 28 , - Professor Desire Collen Will ... ThromboGenics NV (Euronext Brussels: THR), a biotechnology ... disease and cancer,announces today that Patrik De Haes, ... succeed Professor Desire Collen as the Company,s new,Chief ...
    Other Biology Technology:RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 2RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 3RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 4RainDance and Scripps to Collaborate on Targeted Sequencing for 'Wellderly' Study 5Enerkem Expands Executive Management Team 2ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 2ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 3ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer 4
    (Date:3/17/2010)... available in French . , Scientists ... extremely important process for the proper functioning and ... transportation pathway of ,cargo, to and from the ... pathway can have severe consequences, leading to numerous ... complications in immune response. Understanding the mechanisms underlying ...
    (Date:3/17/2010)... the Arctic,s biodiversity reports a 26 per cent decline ... of lemmings, caribou and red knot are some of ... 34 years, according to the first report from The ... on how the Arctic,s ecosystems and wildlife are responding ... may be part of a natural cycle, there is ...
    (Date:3/17/2010)... This release is available in French . ... our gut comes in contact with bacteria, inducing an ... control of inflammation is lost and this can lead ... cancer. Caspase-1, an important protein involved in the mechanism ... of the culprits behind excessive inflammation in the colon. ...
    Breaking Biology News(10 mins):Getting turned on 2Getting turned on 3High Arctic species on thin ice 2Could regulating intestinal inflammation prevent colon cancer? 2FDA Issues Warning for Over the Counter Cold Remedy 49098 1FDA Issues Warning for Over the Counter Cold Remedy 49098 2FDA Issues Warning for Over the Counter Cold Remedy 49098 3Global sunscreen wont save corals 8863 1Global sunscreen wont save corals 8863 2Nutrition Expert Conducts Survey and Reveals How to Eat Your Way to a New Job 49094 1Nutrition Expert Conducts Survey and Reveals How to Eat Your Way to a New Job 49094 2
    ... 2008) The Life Sciences Discovery Fund (LSDF) ... State-based research organizations will receive life sciences program ... health research initiatives will focus on advancing vaccine ... improving the delivery of mental health and substance ...
    ... be important only for bone health, vitamin D is ... the immune system throughout life. The newly recognized disease ... in a report in the December issue (Volume 3, ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ...
    ... ability to view the activity of any chosen gene ... With GeneVision, military commanders could compare gene expression in ... to craving as shoppers moved about a store. "The ... his love-struck dates. , Frightening? Perhaps. Ethically suspect? Certainly. ...
    Other Biology News:Life Sciences Discovery Fund awards health research program grants 2Life Sciences Discovery Fund awards health research program grants 3Life Sciences Discovery Fund awards health research program grants 4Life Sciences Discovery Fund awards health research program grants 5Vitamin D deficiency in infants and nursing mothers carries long-term disease risks 2Real-time gene monitoring developed 2
    Form: Ready to use Applications: Western Blot, ELISA...
    ANTI S. GROUP AG:H...
    ... Bench-Top Open System Chemistry Analyzer for General Chemistries, Specialty Chemistries, QC, Reagent Development, Pharmaceutical Development, ... diode spectrophotometer over 30 user-selectable wavelengths. ... ... ...
    Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
    Biology Products: